Magazine Article

Manufacturing Considerations for Implantable Drug-Delivery Systems

TBMG-48785

08/01/2023

Abstract
Content

Therapy developers are being asked to consider ways to deliver drugs for a longer time period with a single dose. This has spurred innovation in both the oral and parenteral spaces, but the greatest potential for long-acting delivery remains in implantable systems. Because of this, growth for the global implantable drug-delivery market is forecast at 10 percent annually in coming years with an expectation for the market to reach nearly $30 billion (USD) by 2025.1 Contraceptive, ophthalmic, cardiovascular, diabetes, oncology, and autoimmune disease applications are all likely to focus on development of these therapeutic forms.

Meta TagsDetails
Citation
"Manufacturing Considerations for Implantable Drug-Delivery Systems," Mobility Engineering, August 1, 2023.
Additional Details
Publisher
Published
Aug 1, 2023
Product Code
TBMG-48785
Content Type
Magazine Article
Language
English